Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dynorphin and epilepsy

M Simonato1, P Romualdi

  • 1Institute of Pharmacology and Biotechnology Centre, University of Ferrara, Italy.

Progress in Neurobiology
|December 1, 1996
PubMed
Summary
This summary is machine-generated.

Dynorphin, an endogenous opioid, acts as an anticonvulsant in complex partial seizures and some tonic-clonic seizures by inhibiting neurotransmission. Its role in absence seizures is unlikely due to low brain region expression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of a fixed combination of ibuprofen/paracetamol in the management of acute pain: an Italian expert narrative review.

European review for medical and pharmacological sciences·2026
Same author

Early Life Social Isolation Dysregulates Social Reward Processing, BDNF Signaling, and Intracellular Vesicular Sorting in the Nucleus Accumbens of Male and Female Rats.

Journal of neurochemistry·2025
Same author

Early social isolation differentially affects the glucocorticoid receptor system and alcohol-seeking behavior in male and female Marchigian Sardinian alcohol-preferring rats.

Neurobiology of stress·2023
Same author

Sex-dependent effect of inflammatory pain on negative affective states is prevented by kappa opioid receptors blockade in the nucleus accumbens shell.

Neuropharmacology·2023
Same author

Brain-derived neurotrophic factor protects serotonergic neurons against 3,4-methylenedioxymethamphetamine ("Ecstasy") induced cytoskeletal damage.

Journal of neural transmission (Vienna, Austria : 1996)·2022
Same author

From bench to bedside: in vitro and in vivo evaluation of a neonate-focused nebulized surfactant delivery strategy.

Respiratory research·2019

Area of Science:

  • Neuroscience
  • Epilepsy Research
  • Pharmacology

Background:

  • Dynorphin's role in epilepsy is increasingly recognized.
  • Evidence suggests dynorphin involvement in specific seizure types.

Purpose of the Study:

  • To review and synthesize evidence on dynorphin's involvement in different epilepsy types.
  • To evaluate the potential of kappa opioid receptor agonists as anticonvulsants.

Main Methods:

  • Review of electrophysiological, biochemical, and pharmacological studies.
  • Analysis of dynorphin expression and release in brain regions associated with seizures.
  • Assessment of kappa opioid receptor agonist efficacy in seizure models.

Main Results:

Related Experiment Videos

  • Dynorphin is implicated in complex partial seizures, particularly temporal lobe epilepsy, via hippocampal inhibition.
  • Dynorphin's role in generalized tonic-clonic seizures is less clear, with mixed evidence.
  • Dynorphin involvement in generalized absence seizures appears unlikely.
  • Conclusions:

    • Dynorphin acts as an endogenous anticonvulsant in complex partial and some tonic-clonic seizures.
    • Selective kappa opioid receptor agonists may share this anticonvulsant spectrum.
    • Dynorphin's limited expression in the thalamus correlates with its lack of involvement in absence seizures.